World's Best Scientists 2026 revealed!
Furio Pacini

Furio Pacini

D-Index & Metrics

Medicine

D-Index
100
Citations
76061
World Ranking
8097
National Ranking
266

Overview

Furio Pacini is affiliated with the University of Siena in Italy and has made contributions primarily within the field of medicine. Their research focuses extensively on endocrinology, diabetes, and metabolism, with significant work also spanning surgery, genetics, oncology, and epidemiology.

The scientist's research topics cover a range of specialized areas, including:

  • Thyroid Cancer Diagnosis and Treatment
  • Thyroid and Parathyroid Surgery
  • Thyroid Disorders and Treatments
  • Neuroendocrine Tumor Research Advances
  • BRCA Gene Mutations in Cancer
  • Pituitary Gland Disorders and Treatments
  • Cancer Immunotherapy and Biomarkers

Frequent publication venues where Furio Pacini's work appears include:

  • The Journal of Clinical Endocrinology & Metabolism
  • Journal of Endocrinological Investigation
  • European Thyroid Journal
  • Thyroid
  • Best Practice & Research Clinical Endocrinology & Metabolism

The scientist has collaborated with several frequent co-authors, such as:

  • Maria Grazia Castagna
  • Tania Pilli
  • Alessandra Cartocci
  • Silvia Cantara
  • Lucia Brilli

Notable recent papers authored or co-authored by Furio Pacini include:

  • Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy, 2020, Journal of Endocrinological Investigation
  • Long-term Effects of Radioiodine in Toxic Multinodular Goiter: Thyroid Volume, Function, and Autoimmunity, 2020, The Journal of Clinical Endocrinology & Metabolism
  • Radioiodine therapy in the different stages of differentiated thyroid cancer, 2022, Best Practice & Research Clinical Endocrinology & Metabolism
  • Tackling Thyroid Cancer in Europe-The Challenges and Opportunities, 2022, Healthcare
  • Long-Term Clinical Outcome in Familial and Sporadic Papillary Thyroid Carcinoma, 2020, European Thyroid Journal

Furio Pacini's publication record reflects a significant focus on thyroid-related diseases, treatments, and clinical outcomes, indicating an integration of clinical practice insights with research data.

Best Publications

  • 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

    Bryan R. Haugen;Erik K. Alexander;Keith C. Bible;Gerard M. Doherty

  • Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

    David S. Cooper;Gerard M. Doherty;Bryan R. Haugen;Richard T. Kloos

  • European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

    Furio Pacini;Martin Schlumberger;Henning Dralle;Rossella Elisei

  • CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2

    Maria Luisa Brandi;Robert F. Gagel;Alberto Angeli;John P. Bilezikian

  • Revised American thyroid association guidelines for the management of medullary thyroid carcinoma

    Samuel A Wells;Sylvia L Asa;Henning Dralle;Rossella Elisei

  • Medullary thyroid cancer: management guidelines of the American Thyroid Association.

    Richard T. Kloos;Charis Eng;Douglas B. Evans;Gary L. Francis

  • Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

    Marcia S Brose;Christopher M Nutting;Barbara Jarzab;Rossella Elisei

  • The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.

    Charis Eng;Charis Eng;David Clayton;Isabelle Schuffenecker;Gilbert Lenoir

  • A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.

    Ernest L. Mazzaferri;R. J. Robbins;C. A. Spencer;L. E. Braverman

  • A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.

    Bryan R. Haugen;Furio Pacini;Christoph Reiners;Martin Schlumberger

  • 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

    Carel W le Roux;Carel W le Roux;Arne Astrup;Ken Fujioka;Frank Greenway

  • Impact of Routine Measurement of Serum Calcitonin on the Diagnosis and Outcome of Medullary Thyroid Cancer: Experience in 10,864 Patients with Nodular Thyroid Disorders

    Rossella Elisei;Valeria Bottici;Fabiana Luchetti;Giancarlo Di Coscio

  • Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.

    F Pacini;F Pacini;Pw Ladenson;M Schlumberger;A Driedger

  • Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.

    Rossella Elisei;Barbara Cosci;Cristina Romei;Valeria Bottici

  • Recombinant Human Thyrotropin-Stimulated Serum Thyroglobulin Combined with Neck Ultrasonography Has the Highest Sensitivity in Monitoring Differentiated Thyroid Carcinoma

    F Pacini;Eleonora Molinaro;Mg Castagna;Laura Agate

  • Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective.

    Martin Schlumberger;Gertrud Berg;Ohad Cohen;Leonidas Duntas

  • Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens.

    Luca Chiovato;Francesco Latrofa;Lewis E. Braverman;Furio Pacini

  • Iodine Biokinetics and Dosimetry in Radioiodine Therapy of Thyroid Cancer: Procedures and Results of a Prospective International Controlled Study of Ablation After rhTSH or Hormone Withdrawal

    Heribert Hänscheid;Michael Lassmann;Markus Luster;Stephen R. Thomas

  • Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma

    F Pacini;M Fontanelli;L Fugazzola;Rossella Elisei

  • Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer

    Martin J. Schlumberger;Rossella Elisei;Lars Bastholt;Lori J. Wirth

Frequent Co-Authors

Aldo Pinchera
Aldo Pinchera University of Pisa
Rossella Elisei
Rossella Elisei University of Pisa
Martin Schlumberger
Martin Schlumberger University of Paris-Saclay
Fulvio Basolo
Fulvio Basolo University of Pisa
Paolo Miccoli
Paolo Miccoli University of Pisa
Steven I. Sherman
Steven I. Sherman The University of Texas MD Anderson Cancer Center
Enio Martino
Enio Martino University of Pisa
Paolo Vitti
Paolo Vitti University of Pisa
Luigi Bartalena
Luigi Bartalena University of Insubria
Bruce G. Robinson
Bruce G. Robinson University of Sydney

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA, a variety of related online degrees and career pathways are available. Many aspiring healthcare professionals explore alternative routes such as nursing, healthcare administration, or medical billing and coding—often opting for programs that offer greater flexibility or faster entry into the workforce.

For those interested in nursing, it’s important to research what is the easiest nursing program to get into, as entry requirements and acceptance rates can vary widely. Additionally, some do all nursing schools require the teas—a crucial consideration since some schools eliminate standardized testing barriers entirely.

Another popular route is pursuing a career in health administration or the medical record field. There are accelerated healthcare programs online that enable you to earn your degree faster and start working sooner. If finances are a concern, consider looking into medical billing and coding schools that accept fafsa to maximize financial aid opportunities.

Best Scientists Citing Furio Pacini

Trending Scientists

Recently Published Articles